- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1756EUR$2,000USD£1,527GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2448EUR$2,789USD£2,130GBP
- Report
- December 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- October 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- August 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,271USD£3,152GBP
- Report
- October 2025
- 160 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- August 2025
- 199 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2026
- 278 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- October 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2025
- 135 Pages
Global
From €15796EUR$17,995USD£13,742GBP
- Report
- January 2024
- 150 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- August 2022
- 120 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- April 2024
- 115 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- March 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,169GBP
- Report
- December 2024
- 152 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- December 2024
- 30 Pages
Global
From €2414EUR$2,750USD£2,100GBP
- Report
- December 2024
- 30 Pages
Global
From €2414EUR$2,750USD£2,100GBP
- Report
- December 2024
- 30 Pages
Global
From €2414EUR$2,750USD£2,100GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more